Disclaimer
All trademarks, logos and brand names are the property of their respective owners, used here solely for identification & reference only under Section 30(1) of the Trade Marks Act, 1999. We are not affiliated with or endorsed by them unless explicitly stated. By using this website, you agree to these terms.
DESCRIPTION
Empliciti is a prescription cancer drug used to treat multiple myeloma (bone marrow cancer). To buy Empliciti or to know its price contact 3S Corporation.
Manufacture :- Bristol-Myers Squibb Company and AbbVie
ADDITIONAL INFORMATION
Strength Available :- 400 mg per vial
Form :- Injection
Dosage :- 10 mg/kg IV every week for the first 2 cycles and every 2 weeks thereafter until disease progression or unacceptable toxicity:
-Cycles 1 and 2: 10 mg/kg IV once a week on days 1, 8, 15, and 22 of a 28-day cycle
-Cycle 3 and beyond: 10 mg/kg IV once every 2 weeks on days 1 and 15 of a 28-day cycle
Manufacturer recommended infusion rate (at the recommended concentration of 25 mg/mL):
CYCLE 1, DOSE 1:
-Time interval 0 to 30 min; Rate 0.5 mL/min
-Time interval 30 to 60 min; Rate 1 mL/min
-Time interval 60 min or more; Rate 2 mL/min
CYCLE 1, DOSE 2:
-Time interval 0 to 30 min; Rate 3 mL/min
-Time interval 30 min or more; Rate 4 mL/min
CYCLE 1, DOSE 3 AND 4 AND ALL SUBSEQUENT CYCLES:
-Rate 5 mL/min
Storage :- Store at 2°C to 8°C
Is the medicine FDA Approved :- Yes
Date of Approval :- November 30, 2015
SIDE EFFECTS
Common side effects are cough, fever, flu-like symptoms, pain or burning during urination, painful skin rash, liver problems, signs of pneumonia.
PACK SIZE
Pack of 1 vial
3S Corporation is a WHO GDSP approved & licensed Pharmaceutical stockist/wholesaler/distributor/exporter/importer of Empliciti Elotuzumab 400 mg per vial based in India - To buy Empliciti Elotuzumab 400 mg per vial or know its cost price contact us here.
We supply & sell Empliciti Elotuzumab 400 mg per vial for Reference Listed Drugs, Government Tenders, Shortage Lists, Emergency Imports, Name Patient Drugs, Comparator Drug Studies, Un-licensed Importation, clinical trial samples & Bio-Similars.